Zebrowska-Lupina I, Kolber-Postepska B, Markiewicz M, Horubała-Bielak G
Kliniki Kardiologii Ak. Med. w Lublinie.
Wiad Lek. 1994 Apr;47(7-8):241-7.
The dynamics was analysed of changes of arterial blood pressure, plasma kininogen and prekallikrein concentrations and plasma renin activity (PRA) in 50 patients with arterial hypertension, in relation to the type of blood pressure response to captopril. It was shown that after three weeks of treatment with captopril 150 mg daily, in 23 patients (46%) normalization of systolic and diastolic blood pressure occurred, and in 27 patients (54%), despite a significant reduction, blood pressure normalization was not achieved. In both groups of patients a significant decrease of plasma kininogen concentration and an increase of plasma prekallikrein level were found, indicating kininogenase activation and PRA increase. However, only in patients with arterial blood pressure normalization, a return of kininogen concentration to normal value was observed and a twofold increase of PRA in relation to the initial value was noted. Our studies indicate that in patients with arterial hypertension treated with captopril a correlation appears between the changes of plasma kinin system and PRA which determines the mode of blood pressure reaction to captopril.
分析了50例动脉高血压患者的动脉血压、血浆激肽原和前激肽释放酶浓度以及血浆肾素活性(PRA)的变化动态,并将其与卡托普利的血压反应类型相关联。结果显示,在每天服用150mg卡托普利治疗三周后,23例患者(46%)的收缩压和舒张压恢复正常,27例患者(54%)尽管血压显著降低,但未实现血压正常化。在两组患者中均发现血浆激肽原浓度显著降低,血浆前激肽释放酶水平升高,表明激肽原酶激活和PRA增加。然而,仅在动脉血压恢复正常的患者中,观察到激肽原浓度恢复到正常值,且PRA相对于初始值增加了两倍。我们的研究表明,在接受卡托普利治疗的动脉高血压患者中,血浆激肽系统的变化与决定卡托普利血压反应模式的PRA之间存在相关性。